[Pharmacology of aescin-isomers with special reference to alpha-aescin].
D000707:Anaphylaxis / Q000139:chemically induced; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D002712:Chlorides / Q000652:urine; D003345:Corticosterone / Q000097:blood; D003864:Depression, Chemical; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004487:Edema / Q000517:prevention & control; D005260:Female; D006027:Glycosides / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity*; D006168:Guinea Pigs; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D010047:Ovalbumin / Q000037:antagonists & inhibitors; D010946:Plants, Medicinal; D011188:Potassium / Q000652:urine; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000652:urine; D012995:Solubility; D013045:Species Specificity; D013268:Stimulation, Chemical; D013729:Terpenes / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity*
D002712:Chlorides; D006027:Glycosides; D013729:Terpenes; D010047:Ovalbumin; D012964:Sodium; D011188:Potassium; D003345:Corticosterone
Zur Pharmakologie der Aescin-Isomere unter besonderer Berücksichtigung von alpha-Aescin.